
Sanofi Consumer Healthcare India Board Approves Q2 2026 Unaudited Results
Sanofi Consumer Healthcare India Ltd announced that its Board of Directors, in a meeting held on July 28, 2026, has approved the unaudited financial results for the quarter and half-year ended June 30, 2026. The company has submitted these results along with the Limited Review Report from statutory auditors, Price Waterhouse & Co Chartered Accountants LLP, as per SEBI Listing Regulations. The results will be published in newspapers and made available on the company's investor website. The board meeting commenced at 4:00 p.m. and concluded at 6:00 p.m.
Key Highlights
- Board approved unaudited financial results for Q2 and H1 2026.
- Results submitted as per SEBI Listing Regulations.
- Limited Review Report from auditors included.
- Financials to be published in newspapers and on company website.
Price Impact
More from SANOFICONR
Sanofi Consumer Healthcare India declares Unaudited Q1 FY27 results
Sanofi Consumer Healthcare India Ltd Board Approves Unaudited Financial Results
Sanofi Consumer Healthcare India Ltd Board Meeting on July 28, 2026